Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
September 5, 2025 Off

Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology

By GlobeNewswire

SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing…

September 5, 2025 Off

MD Logic Health and Dr. Roxanne Carfora Launch Advanced Cholesterol Support: A Doctor-Created Formula for Heart and Metabolic Wellness

By GlobeNewswire

MD Logic Health® and Dr. Roxanne Carfora have teamed up to launch Advanced Cholesterol Support, a doctor-formulated supplement designed to…

September 5, 2025 Off

Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout

By GlobeNewswire

Results from long-term follow up of patients treated with atrioventricular interval modulation (“AVIM”) therapy show blood pressure-lowering effects are sustained…

September 5, 2025 Off

ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

By GlobeNewswire

SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) — ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA…

September 5, 2025 Off

Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

By GlobeNewswire

SOUTH SAN FRANCISCO, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology…

September 5, 2025 Off

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

By GlobeNewswire

CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and…

September 4, 2025 Off

Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes

By GlobeNewswire

NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…

September 4, 2025 Off

Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

By GlobeNewswire

CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive…

September 4, 2025 Off

UPDATE — vTv Therapeutics to Participate in Upcoming September Investor Conferences

By GlobeNewswire

HIGH POINT, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the…

September 4, 2025 Off

Artelo Biosciences Announces Proposed Underwritten Public Offering

By GlobeNewswire

SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways…

Posts pagination

Previous 1 … 93 94 95 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine